FDA sounds skeptical note on Pfizer booster shot ahead of key vote

.cms-textAlign-left{text-align:left;}.cms-textAlign-center{text-align:center;}.cms-textAlign-right{text-align:right;}.cms-magazineStyles-smallCaps{font-variant:small-caps;}

The Food and Drug Administration refrained from endorsing a Covid-19 booster shot from Pfizer and BioNTech in an analysis posted Wednesday ahead of a crucial advisory committee meeting.

The agency appeared skeptical about the companies’ assertion that an apparent drop in immune protection conferred by their Covid-19 vaccine is likely due to the passage of time, rather than the emergence of the hyper-contagious Delta variant.

Documents released ahead of the FDA vaccine advisory committee meeting Friday, which will focus on Pfizer’s booster application, show the companies

→ Continue reading at Politico

[ufc-fb-comments url="http://www.newyorkmetropolitan.com/news/fda-sounds-skeptical-note-on-pfizer-booster-shot-ahead-of-key-vote"]

Latest Articles

Related Articles